SRA880 is a non-peptide somatostatin sst(1) receptor antagonist which displays a significantly lower affinity for the other human recombinant somatostatin receptors ( pK(d)= 6.0) or a wide range of neurotransmitter receptors, except for the human dopamine D4 receptors. SRA880 positively modulates the release of endogenous SRIF, was found to synergize with imipramine in causing antidepressant-like effects in the tail suspension test.

573984-99-3

C29H36N4O8

568.62

NVP-SRA 880;NVP-SRA-880;NVP-SRA880;NVPSRA880;NVP SRA880;SRA880;SRA880 malonate

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years